Bandaram Pharma Packtech Limited (BOM:524602)
India · Delayed Price · Currency is INR 17.98
+0.64 (3.69%)
At close: Aug 21, 2026
Bandaram Pharma Packtech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 323 | 423 | 556 | 445 | 219 | 9 | |
Market Cap Growth | -21.42% | -24.00% | 25.12% | 103.21% | 2325.18% | 0% |
Enterprise Value | 601 | 669 | 729 | 503 | 250 | 21 |
Last Close Price | 17.98 | 23.53 | 46.23 | 36.87 | 25.16 | 50.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 49.33 | 94.37 | 55.99 | 46.93 | 84.99 | - |
PS Ratio | 0.41 | 0.67 | 1.51 | 1.31 | 1.17 | - |
PB Ratio | 1.03 | 1.35 | 3.52 | 2.95 | 4.26 | 0.30 |
P/TBV Ratio | 1.54 | 2.02 | 4.40 | 3.62 | 7.10 | 0.30 |
P/FCF Ratio | - | - | - | - | - | 0.31 |
P/OCF Ratio | - | - | - | - | - | 0.31 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.76 | 1.06 | 1.97 | 1.48 | 1.33 | - |
EV/EBITDA Ratio | 15.59 | 22.92 | 25.00 | 17.77 | 18.76 | 251.51 |
EV/EBIT Ratio | 21.53 | 34.38 | 31.65 | 23.76 | 33.23 | - |
EV/FCF Ratio | - | - | - | - | - | 0.72 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.76 | 0.76 | 1.08 | 0.81 | 2.77 | - |
Debt / EBITDA Ratio | 6.21 | 8.20 | 5.88 | 4.31 | 10.67 | - |
Net Debt / Equity Ratio | 0.74 | 0.74 | 1.08 | 0.81 | 2.74 | -0.70 |
Net Debt / EBITDA Ratio | 6.02 | 7.95 | 5.84 | 4.29 | 10.55 | -249.11 |
Net Debt / FCF Ratio | - | -4.72 | -3.40 | -2.82 | -3.61 | -0.71 |
Asset Turnover | - | 1.10 | 1.04 | 1.31 | 1.62 | - |
Inventory Turnover | - | 5.02 | 3.96 | 4.82 | - | - |
Quick Ratio | - | 0.93 | 1.41 | 1.29 | 1.04 | 208.33 |
Current Ratio | - | 1.66 | 2.20 | 2.13 | 2.05 | 299.99 |
Return on Equity (ROE) | - | 1.90% | 6.44% | 9.38% | 6.34% | -3.02% |
Return on Assets (ROA) | - | 2.12% | 4.06% | 5.07% | 4.05% | -0.29% |
Return on Invested Capital (ROIC) | 4.26% | 4.45% | 5.79% | 7.29% | 5.92% | -1.98% |
Return on Capital Employed (ROCE) | - | 4.70% | 9.30% | 10.70% | 5.90% | -0.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.43% | 1.06% | 1.79% | 2.13% | 1.18% | -1.12% |
FCF Yield | -15.23% | -11.64% | -9.01% | -9.69% | -17.79% | 323.02% |
Dividend Yield | 0.58% | - | 0.22% | 0.27% | 0.40% | - |
Payout Ratio | - | - | 24.15% | - | - | - |
Buyback Yield / Dilution | - | -49.37% | - | -300.00% | - | -31.75% |
Total Shareholder Return | 0.58% | -49.37% | 0.22% | -299.73% | 0.40% | -31.75% |